These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18454755)

  • 1. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 2. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
    Rockwood K; Fay S; Gorman M
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
    Schwalbe O; Wunderlich S; Kloft C
    Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW; Yik PY; Mok W; Chung CP
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
    Isik AT; Bozoglu E; Naharci MI; Kilic S
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):454-9. PubMed ID: 21335298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
    Mega MS; Dinov ID; Porter V; Chow G; Reback E; Davoodi P; O'Connor SM; Carter MF; Amezcua H; Cummings JL
    Arch Neurol; 2005 May; 62(5):721-8. PubMed ID: 15883258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 8. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
    Formiga F; Fort I; Robles MJ; Rodriguez D; Regalado P
    Dement Geriatr Cogn Disord; 2010; 29(3):198-203. PubMed ID: 20332637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Galantamine].
    Taéron C
    Rev Infirm; 2008 Sep; (143):44-6. PubMed ID: 18788671
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cost-effectiveness of galantamine in a german context].
    Happich M; Schweikert B; Mühlbacher A
    Psychiatr Prax; 2005 Apr; 32(3):142-50. PubMed ID: 15818530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
    Maelicke A
    Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.
    Vellas B; Cunha L; Gertz HJ; De Deyn PP; Wesnes K; Hammond G; Schwalen S;
    Curr Med Res Opin; 2005 Sep; 21(9):1423-9. PubMed ID: 16197661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: Seeing the signs early.
    Leifer BP
    J Am Acad Nurse Pract; 2009 Nov; 21(11):588-95. PubMed ID: 19900220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease.
    Dev H; Agius M; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):367-9. PubMed ID: 20562785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
    Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
    Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of nightmares with galantamine.
    Iraqi A; Hughes TL
    J Am Geriatr Soc; 2009 Mar; 57(3):565. PubMed ID: 19278402
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil.
    Galvin JE; Cornblatt B; Newhouse P; Ancoli-Israel S; Wesnes K; Williamson D; Zhu Y; Sorra K; Amatniek J
    Alzheimer Dis Assoc Disord; 2008; 22(1):30-8. PubMed ID: 18317244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of neuropsychological tests in the Cronos Project].
    Bianchi G; Gasparini M; Caffari B; Sorrentino GC; Bianchi C; Bruno G; Maggini M; Raschetti R; Vanacore N
    Ann Ist Super Sanita; 2005; 41(1):69-74. PubMed ID: 16037653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.